影响PT2N0M0期胸段食管鳞癌术后失败的COX多因素分析结果及其对术后辅助治疗的指导意义
Analysis of Postoperative Failure in Patients with Stage PT2N0M0 Esophageal Squamous Cell Carcinoma and Its Guiding Significance for Postoperative Adjuvant Therapy
DOI: 10.12677/ACM.2021.113170, PDF,   
作者: 段有升, 张宏毅, 杨红杰, 陶 鹤:巴州人民医院放疗科,新疆 库尔勒;沈文斌*:河北医科大学第四医院放疗科,河北 石家庄
关键词: 食管肿瘤/食管癌手术治疗鳞癌PT2N0M0失败原因COX多因素Esophageal Neoplasms/Esophageal Cancer Surgical Treatment Squamous Cell Carcinoma PT2N0M0 Cause of Failure COX Multifactorial
摘要: 目的:分析PT2N0M0期胸段食管鳞癌术后患者的失败原因及其对术后辅助治疗的指导意义。方法:回顾性分析2007年1月至2010年12月在河北医科大学第四医院胸外科接受食管癌手术治疗的213例PT2N0M0期患者,分析其预后影响因素、失败原因等,应用SPSS19.0进行统计学分析,COX模型进行多因素分析。结果:全组出现胸腔内–区域复发54例(25.4%),远处转移27例(12.7%),胸腔内–区域复发合并远处转移患者15例。全组患者1、3、5年总生存率(OS)和无病生存率(DFS)分别为:93.9%、80.7%、71.7%和91.8%、77.3%、69.6%。COX多因素分析结果显示肿瘤组织分化程度为影响患者OS和DFS的独立性指标(P = 0.046、0.007),另外病变部位也为影响患者DFS的独立性预后指标(P = 0.047);食管病变部位为患者胸腔内–区域复发的独立性预后指标(P = 0.014),肿瘤分化程度为影响远处转移的独立性预后指标(P = 0.021)。结论:即使接受了根治性手术切除的PT2N0M0期胸段食管鳞癌患者仍有较高的失败率,建议对于PT2N0M0期胸上段食管鳞癌和分化程度较低的患者应该积极予以术后辅助性治疗,最终结论需进行前瞻性研究证实。
Abstract: Objective: To analyze the causes of failure in PT2N0M0 thoracic esophageal squamous cell carcinoma postoperative patients and analyze the guiding significance of postoperative adjuvant radiotherapy. Methods: We retrospectively analyzed 213 patients with PT2N0M0 who underwent surgical treatment of esophageal cancer in our hospital from January 2007 to December 2010. The prognostic factors and failure reasons were analyzed. SPSS19.0 was used for statistical analysis, and COX model was used for multivariate analysis. Results: There were 54 cases (25.4%) with intrathoracic-regional recurrence in the whole group, 27 cases (12.7%) with distant metastases, and 15 cases with intrathoracic-regional recurrence and distant metastases. The overall survival (OS) and disease-free survival (DFS) of patients in the whole group were 93.9%, 80.7%, 71.7% and 91.8%, 77.3%, and 69.6%, respectively. Cox multivariate analysis showed that the degree of tumor differentiation was an independent index (P = 0.046, 0.007) that affected the OS and DFS of patients, and the location of lesions was also an independent prognostic index (P = 0.047); esophageal lesions were independent predictors of intrathoracic-regional recurrence (P = 0.014). The degree of tumor differentiation was an independent prognostic indicator of distant metastasis (P = 0.021). Conclusion: Even patients with PT2N0M0 thoracic esophageal squamous cell carcinoma undergoing radical resection have higher failure rate. It is recommended that postoperative adjuvant therapy should be actively performed for patients with PT2N0M0 upper thoracic esophageal squamous cell carcinoma and low differentiation. But, the final conclusion needs to be confirmed by forward-looking research.
文章引用:段有升, 张宏毅, 杨红杰, 陶鹤, 沈文斌. 影响PT2N0M0期胸段食管鳞癌术后失败的COX多因素分析结果及其对术后辅助治疗的指导意义[J]. 临床医学进展, 2021, 11(3): 1179-1186. https://doi.org/10.12677/ACM.2021.113170

参考文献

[1] Berry, M.F., Zeyer-Brunner, J., Castleberry, A.W., et al. (2013) Treatment Modalities for T1N0 Esophageal Cancers: A Comparative Analysis of Local Therapy versus Surgical Resection. Journal of Thoracic Oncology, 8, 796-802. ://doi.org/10.1097/JTO.0b013e3182897bf1
[2] Martin, J.T., Worni, M., Zwischenberger, J.B., et al. (2013) The Role of Radiation Therapy in Resected T2N0 Esophageal Cancer: A Population-Based Analysis. The Annals of Thoracic Surgery, 95, 453-458. ://doi.org/10.1016/j.athoracsur.2012.08.049
[3] Shen, W.B., Zhu, S.C., Gao, H.M., et al. (2016) Analysis of Failure Patterns in Patients with Resectable Esophageal Squamous Cell Carcinoma Receiving Chemoradiotherapy. Journal of Cancer Research and Therapeutics, 12, 62-68. ://doi.org/10.4103/0973-1482.146128
[4] Matsuda, S., Takeuchi, H., Kawakubo, H., et al. (2016) Current Advancement in Multidisciplinary Treatment for Resectable cStage II/III Esophageal Squamous Cell Carcinoma in Japan. Annals of Thoracic and Cardiovascular Surgery, 22, 275-283. ://doi.org/10.5761/atcs.ra.16-00111
[5] Xiao, Z.F., Yang, Z.Y., Miao, Y.J., et al. (2005) Influence of Number of Metastatic Lymph Nodes on Survival of Curative Resected Thoracic Esophageal Cancer Patients and Value of Radiotherapy: Report of 549 Cases. International Journal of Radiation Oncology • Biology • Physics, 62, 82-90. ://doi.org/10.1016/j.ijrobp.2004.08.046
[6] Chen, J.Q., Pan, J.J., Zheng, X.W., et al. (2012) Number and Location of Positive Nodes, Postoperative Radiotherapy, and Survival after Esophagectomy with Three-Field Lymph Node Dissection for Thoracic Esophageal Squamous Cell Carcinoma. International Journal of Radiation Oncology • Biology • Physics, 82, 475-482. ://doi.org/10.1016/j.ijrobp.2010.08.037
[7] Wang, S., Wang, Z., Yang, Z., et al. (2016) Postoperative Radiotherapy Improves Survival in Stage pT2N0M0 Esophageal Squamous Cell Carcinoma with High Risk of Poor Prognosis. Annals of Surgical Oncology, 23, 265-272. ://doi.org/10.1245/s10434-015-4622-0
[8] Chen, G., Wang, Z., Liu, X.Y., et al. (2009) Clinical Study of Modified Ivor-Lewis Esophagectomy plus Adjuvant Radiotherapy for Local Control of Stage IIA Squamous Cell Carcinoma in the Mid-Thoracic Esophagus. European Journal of Cardio-Thoracic Surgery, 35, 1-7. ://doi.org/10.1016/j.ejcts.2008.09.002
[9] Shi, H., Zhang, K., Niu, Z.X., et al. (2015) Does Tumour Location Influence Postoperative Long-Term Survival in Patients with Oesophageal Squamous Cell Carcinoma? European Journal of Cardio-Thoracic Surgery, 48, 266-272. ://doi.org/10.1093/ejcts/ezv006
[10] 高玉华, 王玉祥, 李静, 等. 影响pT2N0~1M0期胸段食管癌患者术后疗效的因素分析[J]. 中华肿瘤杂志, 2017, 39(9): 683-688.
[11] 沈文斌, 高红梅, 祝淑钗, 等. pT3N0M0期胸段食管鳞癌患者术后失败原因分析及其术后放疗思考[J]. 中华放射肿瘤学杂志, 2017, 26(4): 394-399.
[12] Chen, S.B., Weng, H.R., Wang, G., et al. (2013) Prognostic Factors and Outcome for Patients with Esophageal Squamous Cell Carcinoma Underwent Surgical Resection Alone: Evaluation of the Seventh Edition of the American Joint Committee on Cancer Staging System for Esophageal Squamous Cell Carcinoma. Journal of Thoracic Oncology, 8, 495-501. ://doi.org/10.1097/JTO.0b013e3182829e2c
[13] Ma, G., Zhang, X., Ma, Q., et al. (2015) A Novel Multivariate Scoring System for Determining the Prognosis of Lymph Node-Negative Esophageal Squamous Cell Carcinoma Following Surgical Therapy: An Observational Study. European Journal of Surgical Oncology, 41, 541-547. ://doi.org/10.1016/j.ejso.2015.01.013
[14] Wang, J., Wu, N., Zheng, Q.F., et al. (2014) Evaluation of the 7th Edition of the TNM Classification in Patients with Resected Esophageal Squamous Cell Carcinoma. World Journal of Gastroenterology, 20, 18397-18403. ://doi.org/10.3748/wjg.v20.i48.18397
[15] Xu, Y., Liu, J., Du, X., et al. (2013) Prognostic Impact of Postoperative Radiation in Patients Undergoing Radical Esophagectomy for Pathologic Lymph Node Positive Esophageal Cancer. Radiation Oncology, 8, Article No. 116. ://doi.org/10.1186/1748-717X-8-116
[16] Situ, D., Wang, J., Lin, P., et al. (2013) Do Tumor Location and Grade Affect Survival in pT2N0M0 Esophageal Squamous Cell Carcinoma? Journal of Thoracic and Cardiovascular Surgery, 146, 45-51. ://doi.org/10.1016/j.jtcvs.2013.01.034
[17] Situ, D., Wei, W., Lin, P., et al. (2013) Do Tumor Grade and Location Affect Survival in Esophageal Squamous Cell Carcinoma? Survival Analysis of 302 Cases of pT3N0M0 Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology, 20, 580-585. ://doi.org/10.1245/s10434-012-2656-0
[18] 王玉祥, 董石磊, 何明, 等. pT1-3N0M0期食管鳞癌二野术后复发和转移的因素分析[J]. 中华放射肿瘤学杂志, 2018, 27(2): 145-149.
[19] 王玉祥, 王丽丽, 李静, 等. T3N0M0期胸段食管鳞癌术后复发或转移的挽救治疗分析[J]. 中华放射肿瘤学杂志, 2016, 25(10): 1070-1073.
[20] Wang, H., Deng, F., Liu, Q. and Ma, Y. (2017) Prognostic Significance of Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma. Pathology—Research and Practice, 213, 842-847. ://doi.org/10.1016/j.prp.2017.01.023
[21] Rice, T.W., Ishwaran, H., Hofstetter, W.L., et al. (2017) Esophageal Cancer: Associations with (pN+) Lymph Node Metastases. Annals of Surgery, 265, 122-129. ://doi.org/10.1097/SLA.0000000000001594
[22] 吴彬, 徐志飞, 孙耀昌, 等. 食管癌的侵犯深度及分化程度与区域淋巴结转移的关系[J]. 第二军医大学学报, 2000, 21(8): 771-773.
[23] 李国仁, 戴建华. 食管癌淋巴结转移研究状况及其治疗策略[J]. 中国肿瘤, 2007, 6(11): 915-919.